UnitedHealth: Q1 Decline Makes Undervalued Stock a Strong Buy With Dividend Upside
It’s been an eventful few months for UnitedHealth Group (NYSE:) shares, which hit an all-time high of $630.73 on November 11, 2024, before plummeting in December following the murder of CEO Brian Thomson.
In February, the stock was then affected by concerns over its pending merger with Amedisys (NASDAQ:). The shares had then fallen to a low of $438.50 on February 21.
The stock climbed steadily and reached a high of $606.36 on April 11, gaining 38% in under two months. But the rally quickly reversed, plunging to $417.12 on Tuesday—its weakest level since October 2021.
UnitedHealth faced a sharp decline following the release of its quarterly results, dropping 22.38% on April 17 and another 6.34% on April 22 after the Easter break. The…
